Form 4: Edgewell Personal Care Executive Receives Restricted Stock Equivalents

Sentiment:

SEC Form 4 Filing


LaTanya Langley, Chief People & Legal Officer at Edgewell Personal Care, was granted 11,062 restricted stock equivalents.

Summary

  • LaTanya Langley, the Chief People & Legal Officer of Edgewell Personal Care, received 11,062 restricted stock equivalents (RSEs) on November 8, 2024.
  • These RSEs will vest and convert into shares of Edgewell common stock in three equal installments on November 8, 2025, November 8, 2026, and November 8, 2027, provided Ms. Langley remains employed by the company on those dates.
  • The vesting of the RSEs may also occur upon death, disability, a change in control, or certain termination events.

Sentiment

Score: 7

Explanation: The document is a routine filing related to executive compensation, which is generally viewed neutrally to slightly positive as it aligns executive interests with shareholders.

Positives

  • The grant of restricted stock equivalents aligns the executive's interests with those of the shareholders.
  • The vesting schedule encourages long-term commitment from the executive.

Risks

  • The vesting of the RSEs is contingent on continued employment, which could be a risk if the executive leaves the company before the vesting dates.

Future Outlook

The document outlines the vesting schedule for the restricted stock equivalents, indicating future potential stock ownership for the executive.

Industry Context

The granting of restricted stock equivalents is a common practice in corporate compensation to align executive interests with shareholder value and encourage long-term commitment.

Comparison to Industry Standards

  • The use of restricted stock equivalents is a standard practice for executive compensation across various industries, including consumer goods, where Edgewell operates.
  • Many companies, such as Procter & Gamble and Unilever, use similar equity-based compensation plans to incentivize their executives.
  • The vesting schedule of one-third each year for three years is also a common vesting structure.

Stakeholder Impact

  • Shareholders may view this as a positive as it aligns executive interests with the long-term performance of the company.
  • Employees may see this as a positive sign of the company's commitment to its leadership.

Next Steps

  • The RSEs will vest according to the schedule outlined in the document, contingent on continued employment.

Key Dates

DateDescription
11/08/2024Date of the grant of 11,062 restricted stock equivalents.
11/08/2025First vesting date for one-third of the RSEs.
11/08/2026Second vesting date for one-third of the RSEs.
11/08/2027Final vesting date for the remaining one-third of the RSEs.
11/12/2024Date the form was signed.

Keywords

restricted stock equivalents, RSE, stock grant, executive compensation, Edgewell Personal Care, LaTanya Langley, vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.